M&A Activity Starts to Pick up in Q2 2023

By Lucy Haggerty

Pharma Deals Review: Vol 2023 Issue 4 (Table of Contents)

Published: 27 Apr-2023

DOI: 10.3833/pdr.v2023.i4.2779     ISSN: 1756-7874

Section: Opinion & Analysis

Fulltext:

Abstract

After a particularly quiet start to 2023, it seems M&A deal making activity in the life science sectoris starting to pick up after two big pharmas announced deals in quick succession...

This page is available to subscribers only.

Not a subscriber? Join here

Why should I subscribe?

Already Registered? Please login using the top left purple box.

Copyright: © IQVIA 2018

PharmaDeals has now moved to a new platform (https://analyticslink.customerportal.iqvia.com). The current PharmaDeals website will be disabled from October 31, 2026. Please update your bookmarks and, if you have any issues accessing the new platform, please contact your IQVIA account manager.

IQVIA™ Pharma Deals: PharmaDeals Review: Article Details